ArticleBritish journal of cancer2024

Primary resistance to immunotherapy in patients with a dMMR/MSI metastatic gastrointestinal cancer: who is at risk? An AGEO real-world study.

Clémence Flecchia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.